Not logged in Share Save
Share Save
Share Save
Share Save
Share Save
Real-world survival outcomes, treatment patterns, and impact of PD-L1 expression among patients with unresectable, stage III NSCLC treated with CRT → durvalumab in Canada: The RELEVANCE study Wheatley-Price, Paul; Navani, Vishal; Pabani, Aliyah; Routy, Bertrand; Snow, Stephanie; Denault, Marie-Helene; Kim, YongJin; Syed, Iqra; Devost, Natalie; Hui, Daphne; Qadeer, Rana A.; Arora, Paul; Velummailum, Russanthy; Springford, Aaron; McKibbon, Chelsea; Ho, Cheryl Share Save
Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management (Nov, 10.1007/s12022-024-09836-x, 2024) Mete, Ozgur; Boucher, Andree; Schrader, Kasmintan A.; Abdel-Rahman, Omar; Bahig, Houda; Ho, Cheryl; Hasan, Olfat Kamel; Lemieux, Bernard; Winquist, Eric; Wong, Ralph; Wu, Jonn; Chau, Nicole; Ezzat, Shereen Share Save
Share Save
Share Save
Share Save
Predictors of Quality of Life Decline in Patients with Oligometastases treated with Stereotactic Ablative Radiotherapy: Analysis of the-Based SABR-5 Phase II Trial Cruz-Lim, E. M.; Mou, B.; Jiang, W.; Liu, M.; Bergman, A.; Schellenberg, D.; Alexander, A.; Berrang, T.; Bang, A.; Chng, N.; Matthews, Q.; Carolan, H.; Hsu, F.; Miller, S.; Atrchian, S.; Chan, E.; Ho, C.; Mohamed, I.; Lin, A.; Huang, V.; Mestrovic, A.; Hyde, D.; Lund, C.; Pai, H.; Valev, B.; Lefresnex, S.; Tyldesley, S.; Olson, R.; Baker, S. Share Save
ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results Anagnostou, Valsamo; Ho, Cheryl; Nicholas, Garth; Juergens, Rosalyn Anne; Sacher, Adrian; Fung, Andrea S.; Wheatley-Price, Paul; Laurie, Scott A.; Levy, Benjamin; Brahmer, Julie R.; Balan, Archana; Niknafs, Noushin; Avrutin, Egor; Zhu, Liting; Sausen, Mark; Bradbury, Penelope A.; O'Donnell-Tormey, Jill; Gaudreau, Pierre Olivier; Ding, Keyue; Dancey, Janet Share Save
Share Save
TOGETHER: Pooled real-world datasets of METex14 skipping NSCLC and adjusted comparison of upfront (chemo-) immunotherapy with tepotinib from VISION Christopoulos, P.; Ekman, S.; Guisier, F.; Ho, C.; Blasi, M.; Brunnstrom, H.; Cvetkovic, J.; Kazdal, D.; Kuon, J. B.; de Flon, F. Haglund; Stenzinger, A.; Wong, S.; Hatswell, A.; McLean, T.; Bergman, S.; Orlowski, K.; Grupp, A. M. OBrate; Vioix, H.; Thomas, M. Share Save
Share Save
A ctDNA-directed, multi-center phase II study of molecular response adaptive immuno-chemotherapy in patients with non-small cell lung cancer: Analysis of Stage 1 of CCTG BR.36 Anagnostou, Valsamo K.; Ho, Cheryl; Nicholas, Garth; Juergens, Rosalyn Anne; Sacher, Adrian; Fung, Andrea; Wheatley-Price, Paul; Laurie, Scott; Levy, Benjamin; Brahmer, Julie; Balan, Archana; Niknafs, Noushin; Avrutin, Egor; Zhu, Liting; Sausen, Mark; Bradbury, Penelope; O'Donnell-Tormey, Jill; Gaudreau, Pierre-Olivier; Ding, Keyue; Dancey, Janet Share Save
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial Chan, A. T. C.; Lee, V. H. F.; Hong, R-L; Ahn, M. -J.; Chong, W. Q.; Kim, S. -B.; Ho, G. F.; Caguioa, P. B.; Ngamphaiboon, N.; Ho, C.; Aziz, M. A. S. A.; Ng, Q. S.; Yen, C. -J.; Soparattanapaisarn, N.; Ngan, R. K. -C; Kho, S. K.; Tiambeng, M. L. A.; Yun, T.; Sriuranpong, V.; Algazi, A. P.; Cheng, A.; Massarelli, E.; Swaby, R. F.; Saraf, S.; Yuan, J.; Siu, L. L. Share Save
Share Save
A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada Regier, Dean A.; Pollard, Samantha; McPhail, Melanie; Bubela, Tania; Hanna, Timothy P.; Ho, Cheryl; Lim, Howard J.; Chan, Kelvin; Peacock, Stuart J.; Weymann, Deirdre Share Save
Share Save
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
